60526-69-4

Basic information

• Product Name: Phenol, 4-(1,1-dimethylheptyl)-2,6-dimethoxy-
• CAS NO: 60526-69-4
• Molecular Formula: C17H28O3
• Molecular Weight: 280.408
• Mol File: 60526-69-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Phenol, 4-(1,1-dimethylheptyl)-2,6-dimethoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 4-(1,1-dimethylheptyl)-2,6-dimethoxy-(60526-69-4)
• EPA Substance Registry System: Phenol, 4-(1,1-dimethylheptyl)-2,6-dimethoxy-(60526-69-4)

Safety Data

• Hazardous Substances Data: 60526-69-4(Hazardous Substances Data)

Upstream product

• 91-10-1 1,3-dimethoxy-2-hydroxy-benzene 
• 628-44-4 2-methyl-2-octanol 

Downstream Products

• 60526-75-2 4-(1',1'-dimethylheptyl)-2,6-dimethoxyphenyl diethylphosphate 
• 87613-50-1 3-(1,1-dimethylheptyl)-5-methoxyphenol 
• 181764-33-0 1-bromo-4-(1,1-dimethylheptyl)-2-methoxybenzene 
• 866398-21-2 1-(1,1-dimethylheptyl)-3-methoxybenzene 
• 83002-04-4 CP 55,940 
• 60526-81-0 1-(1',1'-dimethylheptyl)-3,5-dimethoxybenzene 
• 866398-07-4 (7R,8R)-7-[4-(1,1-dimethylheptyl)-2-methoxyphenyl]-8-(2-[1,3]dioxolan-2-ylethyl)-1,4-dioxaspiro[4,5]decane 
• 866398-09-6 3-{(7R,8R)-7-[4-(1,1-dimethylheptyl)-2-methoxyphenyl]-1,4-dioxaspiro[4,5]dec-8-yl}propan-1-ol 
• 866398-05-2 (1R,4R,5R,8S)-4-[4-(1,1-dimethylheptyl)-2-methoxyphenyl]-8-methoxymethoxybicyclo[3.3.1]non-3-en-2-one 
• 866398-11-0 (1R,3R,4R)-3-[4-(1,1-dimethylheptyl)-2-methoxyphenyl]-4-(3-hydroxypropyl)cyclohexanol 
• 866398-19-8 trifluoromethanesulfonic acid 3-(1,1-dimethylheptyl)-5-methoxyphenyl ester 
• 866398-16-5 trifluoromethanesulfonic acid 4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl ester 

Relevant articles and documents

METHODS AND COMPOSITIONS RELATING TO ULTRAPURE 5-(1,1-DIMETHYLHEPTYL)-RESORCINOL

The invention provides methods and compositions relating to an ultrapure formulation of 5-(1,1-dimethylheptyl)-resorcinol (ultrapure DMHR). The invention features methods for making ultrapure DMHR, including methods that minimize the production of unwanted side products (e.g., the production of homologous alkyl-chain impurities). The invention also features methods of making cannabinoids, such as (6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyl-2-octanyl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene-9-carboxylic acid (ajulemic acid), using ultrapure DMHR, including methods that minimize the production of unwanted side products (e.g., the production of homologous alkyl-chain impurities) in the resulting cannabinoid preparation.

High enantiomeric purity dexanabinol for pharmaceutical compositions

The present invention relates to a synthetic cannabinoid, dexanabinol, of enantiomeric purity in excess of 99.90%, or to a pharmaceutically acceptable salt, ester or solvate of said compound. The present invention also relates to pharmaceutical grade compositions comprising said compound of high enantiomeric purity, and uses thereof for prevention and treatment of neurological disorders, chronic degenerative diseases, CNS poisoning, cognitive impairment, inflammatory diseases or disorders, autoimmune diseases or disorders, pain, emesis, glaucoma and wasting syndromes.